New drugs transform weight loss industry

May 9, 2024
Weight Watchers holds its annual shareholder meeting today, which includes a presentation by departing board member Oprah Winfrey.
Since weight loss drugs like Wegovy have come onto the scene, the weight loss industry has grown from $76 billion a year to nearly $90 billion in 2023.
Scott Olson/Getty Images

How a weight loss drug's approval could affect insurance premiums

Nov 10, 2023
The FDA's approval of Eli Lilly's Zepbound could signal more insurers paying for the use of such drugs. Demand is great so the costs could be big and push up premiums.
Eli Lilly’s newly FDA-approved weight loss drug, Zepbound, is priced roughly 21% lower than competitor Novo Nordisk’s Wegovy.
Eli Lilly